"Paid clinical trials enrolling now. Study medication and all study related care provided at no cost, no insurance needed. Compensation provided after every completed visit."

During the past decade, Centex Studies, Inc. conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 43 clinical trials were completed, i.e. on average, 81.1% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 28 clinical trials were completed. i.e. 112% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centex Studies, Inc." #1 sponsor was "Pfizer" with 11 trials, followed by "Repros Therapeutics Inc." with 4 trials sponsored, "Bayer" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centex Studies, Inc." #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "DSM Nutritional Products, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Centex Studies, Inc." are "Low Back Pain" (4 trials), "Crohn Disease" (3 trials), "Secondary Hypogonadism" (3 trials), "Acute Pain" (2 trials) and "Adhesive Capsulitis" (2 trials). Many other conditions were trialed in "Centex Studies, Inc." in a lesser frequency.

Most popular intervention types in "Centex Studies, Inc." are "Drug" (58 trials), "Other" (16 trials), "Biological" (15 trials), "Dietary Supplement" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "placebo" (6 trials), "Naproxen" (3 trials), "Ozanimod" (3 trials) and "Androxal" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centex Studies, Inc." are 60 trials for "All" genders, 8 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Centex Studies, Inc.". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 48 completed trials in Centex Studies, Inc., undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Centex Studies, Inc., 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".